NCT06008990View on ClinicalTrials.gov

Maternal Brain Imaging in Opioid Use Disorder

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

April 1, 2026

Study Completion Date

July 31, 2026

Conditions
Opioid Use DisorderSubstance-Related DisordersSubstance UsePregnancy RelatedNarcotic-Related DisordersBuprenorphine Dependence
Interventions
DRUG

Buprenorphine

Pregnant mother must be taking Buprenorphine

DIAGNOSTIC_TEST

Maternal Brain MRI

Maternal Brain MRI obtained between 24-32 week gestation

OTHER

Blood Samples

During the MRI visit blood samples will be drawn: one hour prior to MRI, immediately before MRI, and one hour post MRI to test for Buprenorphine levels.

BEHAVIORAL

Questionnaires

Participants will answer questionnaires about their medical history, pregnancy, and substance use.

Trial Locations (1)

46202

RECRUITING

Riley Hospital for Children, Indianapolis

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Indiana University

OTHER